149 related articles for article (PubMed ID: 15509046)
1. [Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis].
Mubiayi N; Coutty N; Detourmignies L; Le Goueff F; Decocq J; Delahousse G
Presse Med; 2004 Aug; 33(14 Pt 1):930-3. PubMed ID: 15509046
[TBL] [Abstract][Full Text] [Related]
2. [Congenital toxoplasmosis. Tolerability of the sulfadoxine-pyrimethamine combination. 24 cases].
Maisonneuve H; Faber C; Piens MA; Garin JP
Presse Med; 1984 Mar; 13(14):859-62. PubMed ID: 6231609
[TBL] [Abstract][Full Text] [Related]
3. Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
Villena I; Quereux C; Pinon JM
Prenat Diagn; 1998 Jul; 18(7):754-6. PubMed ID: 9706662
[No Abstract] [Full Text] [Related]
4. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
Mandelbrot L; Kieffer F; Sitta R; Laurichesse-Delmas H; Winer N; Mesnard L; Berrebi A; Le Bouar G; Bory JP; Cordier AG; Ville Y; Perrotin F; Jouannic JM; Biquard F; d'Ercole C; Houfflin-Debarge V; Villena I; Thiébaut R;
Am J Obstet Gynecol; 2018 Oct; 219(4):386.e1-386.e9. PubMed ID: 29870736
[TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis.
Bosch-Driessen LH; Verbraak FD; Suttorp-Schulten MS; van Ruyven RL; Klok AM; Hoyng CB; Rothova A
Am J Ophthalmol; 2002 Jul; 134(1):34-40. PubMed ID: 12095805
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment.
Teil J; Dupont D; Charpiat B; Corvaisier S; Vial T; Leboucher G; Wallon M; Peyron F
Pediatr Infect Dis J; 2016 Jun; 35(6):634-8. PubMed ID: 26906163
[TBL] [Abstract][Full Text] [Related]
7. High Frequency of Bone Marrow Depression During Congenital Toxoplasmosis Therapy in a Cohort of Children Identified by Neonatal Screening in Minas Gerais, Brazil.
Carellos EVM; de Andrade JQ; Romanelli RMC; Tibúrcio JD; Januário JN; Vasconcelos-Santos DV; Figueiredo RM; de Andrade GMQ;
Pediatr Infect Dis J; 2017 Dec; 36(12):1169-1176. PubMed ID: 28151845
[TBL] [Abstract][Full Text] [Related]
8. Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine.
Schmidt DR; Hogh B; Andersen O; Hansen SH; Dalhoff K; Petersen E
Eur J Pediatr; 2006 Jan; 165(1):19-25. PubMed ID: 16133245
[TBL] [Abstract][Full Text] [Related]
9. Pancytopenia due to pyrimethamine triggered by transplant-associated microangiopathy after allogeneic bone marrow transplantation.
Mori T; Kato J; Okamoto S
J Infect Chemother; 2011 Dec; 17(6):866-7. PubMed ID: 21674200
[TBL] [Abstract][Full Text] [Related]
10. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
[TBL] [Abstract][Full Text] [Related]
11. [Congenital toxoplasmosis following infection occurring late in pregnancy].
Ben Abdallah R; Siala E; Maatoug R; Souissi O; Aoun K; Bouratbine A
Arch Pediatr; 2011 Jul; 18(7):758-60. PubMed ID: 21632221
[TBL] [Abstract][Full Text] [Related]
12. [Transplacental passage of the pyrimethamine-sulfadoxine combination in the prenatal treatment of congenital toxoplasmosis].
Dorangeon P; Fay R; Marx-Chemla C; Leroux B; Harika G; Dupouy D; Quereux C; Choisy H; Pinon JM; Wahl P
Presse Med; 1990 Dec 22-29; 19(44):2036. PubMed ID: 2148622
[No Abstract] [Full Text] [Related]
13. [In utero treatment of congenital toxoplasmosis with a pyrimethamine-sulfadiazine combination].
Couvreur J
Presse Med; 1991 Jun; 20(24):1136. PubMed ID: 1830148
[No Abstract] [Full Text] [Related]
14. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
[TBL] [Abstract][Full Text] [Related]
16. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group.
Villena I; Aubert D; Leroux B; Dupouy D; Talmud M; Chemla C; Trenque T; Schmit G; Quereux C; Guenounou M; Pluot M; Bonhomme A; Pinon JM
Scand J Infect Dis; 1998; 30(3):295-300. PubMed ID: 9790140
[TBL] [Abstract][Full Text] [Related]
17. [Significance of post-partum diagnosis of congenital toxoplasmosis primary maternal infection at the end of the pregnancy].
Wirden M; Botterel F; Romand S; Ithier G; Bourée P
J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):566-7. PubMed ID: 10598352
[TBL] [Abstract][Full Text] [Related]
18. Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case-control study.
Reiter-Owona I; Hlobil H; Enders M; Klarmann-Schulz U; Gruetzmacher B; Rilling V; Hoerauf A; Garweg JG
Eur J Med Res; 2020 Nov; 25(1):59. PubMed ID: 33228795
[TBL] [Abstract][Full Text] [Related]
19. Sulfadiazine Hypersensitivity and Desensitization in Children With Congenital Toxoplasmosis: A Report on Two Cases.
Yamamoto K; Kutsuna S; Kato Y; Goishi K; Shichino H; Ohmagari N;
Pediatr Infect Dis J; 2021 Apr; 40(4):324-326. PubMed ID: 33181786
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P
Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
